Scholars Central

Research articlePublished 25 Feb 2024

AREST Migraine (An Evaluation of Riboflavin 200mg + Magnesium 200 combination Efficacy and Safety in Migraine Headache)

Authors: Harmohan Sahoo, An, G Diwan, Manjusha Patanka

International Journal of Clinical Skills

Volume 18 · Issue 2 · Pages 204–208

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Migraine is a common cause of recurrent headaches. Although drugs for prophylaxis of migraine are effective in reducing the frequency and severity of migraine headaches, less than 13% of patients take prophylactic medications. Often, adverse drug reactions lower the adherence of patients to prophylactic therapies. Riboflavin and magnesium have been demonstrated to be effective agents for prophylaxis of migraine. Methodology: 69 neurologists from across India participated in the study. 699 patients diagnosed with migraine were enrolled in the study. Patients were treated with the combination of Riboflavin 200 mg and Magnesium 200 (One tablet twice a day) for duration of 3 months. The primary endpoint was a reduction in migraine headache frequency per month as per the diary reviewed at follow-up. The secondary endpoint was a reduction in pain intensity as per headache severity score (Wong-Baker Faces Rating Scale) at end of treatment as compared to baseline. The safety of the treatment was assessed by the adverse events reported by the patients during the study. Results: The mean duration of migraine was 14.29 months ± 16.48 months. A 3-fold reduction in frequency and pain intensity of migraine was observed after treatment with the combination of magnesium, and riboflavin. 96% of physicians rated the efficacy of the combination of magnesium, and riboflavin treatment as Excellent to good Conclusion: The need for prophylactic therapy for migraine is increasing since migraine adversely affects work-life balance in patients. Current evidence proves the efficacy and safety of the combination of magnesium and riboflavin in reducing the frequency and severity of migraine attacks. The fixed dose formulation of magnesium and riboflavin has a definite place in the prevention of migraine in the real-world setting.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in International Journal of Clinical Skills.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInternational Journal of Clinical Skills
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Harmohan Sahoo”
  • BylineArticles whose byline prints “An”
  • BylineArticles whose byline prints “G Diwan”
  • BylineArticles whose byline prints “Manjusha Patanka”